Cannabinoids for Taxane Induced Peripheral Neuropathy
Status:
Recruiting
Trial end date:
2025-10-31
Target enrollment:
Participant gender:
Summary
Taxane-induced peripheral neuropathy (TIPN) affects a significant number of women undergoing
breast cancer treatment. Some patients may need to shorten their course of treatment, and do
not receive the full benefit of chemotherapy as a result. Rodent studies have shown that the
cannabinoids may significantly improve hyperalgesia and allodynia induced by paclitaxel. The
goal of this study is to investigate the cannabinoids THC and CBD for TIPN.